SEC Company Response from Novo Integrated Sciences, Inc. (NVOS) (CIK 0001138978) — Oct 7, 2022
Novo Integrated Sciences, Inc. (NVOS) (CIK 0001138978)
Date: Oct. 7, 2022 · CIK: 0001138978 · Accession: 0001493152-22-027994
AI Filing Summary & Sentiment
File numbers found in text: 333-267401
Show Raw Text
CORRESP
1
filename1.htm
Novo
Integrated Sciences, Inc.
11120
NE 2nd Street, Suite 100
Bellevue,
WA 98004
October
7, 2022
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Novo
Integrated Sciences, Inc.
Registration
Statement on Form S-1
CIK
No. 0001138978
File
No. 333-267401
Ladies
and Gentlemen:
In
accordance with Rule 461 of the Securities Act of 1933, as amended, Novo Integrated Sciences, Inc. hereby respectfully requests that
the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 5:00 p.m. Eastern
Time on Wednesday, October 12, 2022, or as soon thereafter as possible.
*
* * *
Very
Truly Yours,
Novo Integrated
Sciences, Inc.
/s/
Robert Mattacchione
Robert Mattacchione
Chief Executive Officer